Heart failure combination pill study
Part of Heart & circulation clinical trials.
This study tests a single pill that combines several heart failure medicines to see if it helps people with a weakened heart pump feel better and stay out of the hospital. It is being done in Sri Lanka and may offer a simpler way to take multiple medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with heart failure with reduced ejection fraction (a weakened heart pump, with an ejection fraction of 40% or less).
- You have symptoms like shortness of breath or fatigue (New York Heart Association class II, III, or IV).
- You do not have severe kidney problems, high potassium, low blood pressure, or certain heart rhythm issues.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You are not currently participating in another interventional clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests tools to help doctors and patients work together to start or adjust heart failure medicines. You may qualify if your heart's pumping strength is low and you are missing certain recommended medications.
This trial tests a 'polypill' (a combination of several medicines in one pill) to prevent heart failure in people with type 2 diabetes and kidney disease. It may help reduce your risk of developing heart muscle problems.
This trial tests a single 'polypill' that combines several medicines for people with high blood pressure, high cholesterol, and type 2 diabetes. The goal is to see if taking one pill each day helps control these conditions better than usual care.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
This study tests an investigational medication called elecoglipron to see if it can improve heart and blood vessel outcomes in people with heart failure with preserved or mildly reduced ejection fraction. If you join, you will receive either the study drug or a placebo, and your heart health will be monitored over time.
This trial tests whether switching to a single pill that combines two blood pressure medicines helps control high blood pressure better than taking two separate pills. It might make treatment simpler and more effective.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.